Position history for UBS Group AG's holdings in CIDARA THERAPEUTICS INC
UBS Group AG holds 1.1M shares of CDTX (CIDARA THERAPEUTICS INC), worth $237.4M as of 2025-Q4. The position was increased (++127.0% shares). CDTX represents 0.0% of UBS Group AG's portfolio.
Current Value
$237.4M
Current Shares
1.1M
Total Value Change
+$237.4M
Total Shares Change
+1.1M
Other major holders of CDTX: RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock, Inc., HBK INVESTMENTS L P
Increased |
| 1.1M |
+127.0% |
| $237.4M |
| 0.0% |
| $220.80 |
50 |
| 2025-Q3 | Increased | 473,554 | +166.2% | $45.3M | 0.0% | $95.26 | 47 |
| 2025-Q2 | Increased | 177,910 | +166.3% | $8.7M | 0.0% | $49.45 | 44 |
| 2025-Q1 | Increased | 66,813 | +42.5% | $1.4M | 0.0% | $22.39 | 34 |
| 2024-Q4 | Increased | 46,871 | +697.5% | $1.3M | 0.0% | $25.25 | 41 |
| 2024-Q3 | Increased | 5,877 | +300.6% | $63,178 | 0.0% | $10.74 | 23 |
| 2024-Q2 | Decreased | 1,467 | -68.8% | $17,516 | 0.0% | $11.94 | 0 |